Correction

04/22/2013

A summary in the April 12 edition of DiabetesPro SmartBrief gave the incorrect name of the drug that showed the lowest risk of new-onset diabetes for participants in a meta-analysis. The name of the drug is pravastatin. SmartBrief regrets the error.

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ